The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, carkl, and causes cystinosis if mutated in a critical region

被引:31
作者
Phornphutkul, C
Anikster, Y
Huizing, M
Braun, P
Brodie, C
Chou, JY
Gahl, WA
机构
[1] NICHHD, Sect Human Biochem Genet, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA
[2] Bar Ilan Univ, Ramat Gan, Israel
关键词
D O I
10.1086/323484
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Although >55 CTNS mutations occur in patients with the lysosomal storage disorder cystinosis, no regulatory mutations have been reported, because the promoter has not been defined. Using CAT reporter constructs of sequences 5' to the CTNS coding sequence, we identified the CTNS promoter as the region encompassing nucleotides -316 to +1 with respect to the transcription start site. This region contains an Sp-1 regulatory element (GGCGGCG) at positions -299 to -293, which binds authentic Sp-1, as shown by electrophoretic-mobility-shift assays. Three patients exhibited mutations in the CTNS promoter. One patient with nephropathic cystinosis carried a -295 G -->C substitution disrupting the Sp-1 motif, whereas two patients with ocular cystinosis displayed a -303 G -->T substitution in one case and a -303 T insertion in the other case. Each mutation drastically reduced CAT activity when inserted into a reporter construct. Moreover, each failed either to cause a mobility shift when exposed to nuclear extract or to compete with the normal oligonucleotide's mobility shift. The CTNS promoter region shares 41 nucleotides with the promoter region of an adjacent gene of unknown function, CARKL, whose start site is 501 bp from the CTNS start site. However, the patients' CTNS promoter mutations have no effect on CARKL promoter activity. These findings suggest that the CTNS promoter region should be examined in patients with cystinosis who have fewer than two coding-sequence mutations.
引用
收藏
页码:712 / 721
页数:10
相关论文
共 29 条
[1]   Bidirectional promoter connects the poly(ADP-ribose) polymerase 2 (PARP-2) gene to the gene for RNase P RNA -: Structure and expression of the mouse PARP-2 gene [J].
Amé, JC ;
Schreiber, V ;
Fraulob, V ;
Dollé, P ;
de Murcia, G ;
Niedergang, CP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :11092-11099
[2]   Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS) [J].
Anikster, Y ;
Lucero, C ;
Touchman, JW ;
Huizing, M ;
McDowell, G ;
Shotelersuk, V ;
Green, ED ;
Gahl, WA .
MOLECULAR GENETICS AND METABOLISM, 1999, 66 (02) :111-116
[3]   Ocular nonnephropathic cystinosis: Clinical, biochemical, and molecular correlations [J].
Anikster, Y ;
Lucero, C ;
Guo, JR ;
Huizing, M ;
Shotelersuk, V ;
Bernardini, I ;
McDowell, G ;
Iwata, F ;
Kaiser-Kupfer, MI ;
Jaffe, R ;
Thoene, J ;
Schneider, JA ;
Gahl, WA .
PEDIATRIC RESEARCH, 2000, 47 (01) :17-23
[4]  
Anikster Y, 1999, HUM MUTAT, V14, P454, DOI 10.1002/(SICI)1098-1004(199912)14:6<454::AID-HUMU2>3.0.CO
[5]  
2-H
[6]   Severity of phenotype in cystinosis varies with mutations in the CTNS gene:: predicted effect on the model of cystinosin [J].
Attard, M ;
Jean, G ;
Forestier, L ;
Cherqui, S ;
van't Hoff, W ;
Broyer, M ;
Antignac, C ;
Town, M .
HUMAN MOLECULAR GENETICS, 1999, 8 (13) :2507-2514
[7]  
AULA P, 2001, METABOLIC MOL BASES, P5109
[8]   CLINICAL AND LABORATORY FINDINGS IN THE OCULOCEREBRORENAL SYNDROME OF LOWE, WITH SPECIAL REFERENCE TO GROWTH AND RENAL-FUNCTION [J].
CHARNAS, LR ;
BERNARDINI, I ;
RADER, D ;
HOEG, JM ;
GAHL, WA .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) :1318-1325
[9]   Molecular characterization of CTNS deletions in nephropathic cystinosis:: Development of a PCR-based detection assay [J].
Forestier, L ;
Jean, G ;
Attard, M ;
Cherqui, S ;
Lewis, C ;
van't Hoff, W ;
Broyer, M ;
Town, M ;
Antignac, C .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (02) :353-359
[10]  
Gahl W.A., 2001, METABOLIC MOL BASES, P5085